Ciprandi G - Search Results

1

New approaches for identifying and testing potential new anti-asthma agents.

Licari A, Castagnoli R, Brambilla I, Marseglia A, Tosca MA, Marseglia GL, Ciprandi G. Licari A, et al. Among authors: ciprandi g. Expert Opin Drug Discov. 2018 Jan;13(1):51-63. doi: 10.1080/17460441.2018.1396315. Epub 2017 Oct 31. Expert Opin Drug Discov. 2018. PMID: 29077521 Review.

2

Topical acetylsalicylic acid in the treatment of allergic pollinosic conjunctivitis.

Ciprandi G, Buscaglia S, Tosca M, Canonica GW. Ciprandi G, et al. J Investig Allergol Clin Immunol. 1992 Jan-Feb;2(1):15-8. J Investig Allergol Clin Immunol. 1992. PMID: 1342877 Clinical Trial.

3

Topical anti-inflammatory drugs in the treatment of allergic pollinosic conjunctivitis: a comparative double-blind study.

Ciprandi G, Buscaglia S, Cerqueti MP, Saccà S, Tosca M, Canonica GW. Ciprandi G, et al. J Investig Allergol Clin Immunol. 1992 Sep-Oct;2(5):248-52. J Investig Allergol Clin Immunol. 1992. PMID: 1342906 Clinical Trial.

4

Comparative effects of terfenadine and loratadine in the treatment of hay fever.

Ciprandi G, Iudice A, Tosca MA, Ruffoni S, Buscaglia S, Canonica GW. Ciprandi G, et al. J Investig Allergol Clin Immunol. 1991 Dec;1(6):368-72. J Investig Allergol Clin Immunol. 1991. PMID: 1669595 Review.

5

Non-steroidal treatment of pollen-induced conjunctivitis: comparison of different pharmacological protocols.

Ciprandi G, Cerqueti PM, Sacca S, Ciurlo G, Tosca MA, Canonica GW. Ciprandi G, et al. Allergy. 1991 Jul;46(5):393-5. doi: 10.1111/j.1398-9995.1991.tb00604.x. Allergy. 1991. PMID: 1928663 Clinical Trial.

6

Lodoxamide treatment of allergic conjunctivitis.

Cerqueti PM, Ricca V, Tosca MA, Buscaglia S, Ciprandi G. Cerqueti PM, et al. Among authors: ciprandi g. Int Arch Allergy Immunol. 1994 Oct;105(2):185-9. doi: 10.1159/000236823. Int Arch Allergy Immunol. 1994. PMID: 7920019 Clinical Trial.

7

Allergen-specific conjunctival challenge in children with allergic asthma: a clinical tool.

Ciprandi G, Tosca MA, Fasce L, Canonica GW. Ciprandi G, et al. Allergy. 1994 Jul;49(6):489-91. doi: 10.1111/j.1398-9995.1994.tb00847.x. Allergy. 1994. PMID: 8074273 No abstract available.

8

Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma.

Fasce L, Ciprandi G, Pronzato C, Cozzani S, Tosca MA, Grimaldi I, Canonica GW. Fasce L, et al. Among authors: ciprandi g. Int Arch Allergy Immunol. 1996 Mar;109(3):272-6. doi: 10.1159/000237249. Int Arch Allergy Immunol. 1996. PMID: 8620097 Clinical Trial.

9

Cetirizine treatment of allergic cough in children with pollen allergy.

Ciprandi G, Tosca M, Ricca V, Passalacqua G, Fregonese L, Fasce L, Canonica GW. Ciprandi G, et al. Allergy. 1997 Jul;52(7):752-4. doi: 10.1111/j.1398-9995.1997.tb01233.x. Allergy. 1997. PMID: 9265991 Clinical Trial.

10

Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.

Ciprandi G, Tosca M, Ricca V, Passalacqua G, Riccio AM, Bagnasco M, Canonica GW. Ciprandi G, et al. Clin Exp Allergy. 1997 Oct;27(10):1160-6. Clin Exp Allergy. 1997. PMID: 9383256 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

904 results

Search Page